Subquinocin is a CYLD inhibitor that suppresses deubiquitinating enzymes (DUB) of the USP family. By inhibiting CYLD, Subquinocin enhances the activation of the NF-kappaB and IFN pathways. Additionally, Subquinocin facilitates the activation of IRF3 and/or IRF7 in the RIG-I-mediated interferon pathway.
Formula:
C20H27N3O4S
Target:
DUB|||NF-kappaB|||IFNAR
* VAT and and shipping costs not included. Errors and price changes excepted
